Thanks to Rousselot’s SiMoGelTM, the renowned contract manufacturer is the first company in Europe to successfully qualify the production of gelatin-based nutraceutical gummies. A revolutionary solution, SiMoGel was launched in 2018 and enables the production of fortified gummies in a starch free environment, eliminating the risk of cross-contamination associated with the production in starch molds. The optimized production process enables to create gummies with unmatched gelatin texture with only a few minutes of drying.

The two teams worked closely on-site from the qualification process throughout all industrial trials to develop a specific sugar-free recipe, to optimize the production process and lower the production costs.

“The partnership between Pharmatech and Rousselot goes back a long way and we were delighted to support them in this pioneering project with SiMoGel, especially since they already had the necessary equipment for molding the gummies. It was a pleasure to see Pharmatech operators produce high-quality, fortified gummies within a few hours.” explained Jeff Daelman, Product & BD manager Rousselot.

“SiMoGel was proposed to us in early 2018”, Geir Andreas Lund, Business Manager Pharmatech, said. “Pharmatech was looking for a stable gelatin-based formulation, starch free and easy to produce and SiMoGel sounded perfect for our innovation projects. By using SiMoGel we now have the ability to produce more complex formulations with ingredients that are not suitable for standard gelatin qualities.”

“The fact that SiMoGel is also available in a bovine version is an added benefit which opens up a larger market”, continues Lund.“Rousselot made the formulation process extremely smooth by providing us with SiMoGel samples and assisting on-site during the trials. Thanks to the combined effort of both our teams and the good technical advice from Rousselot, the end result was very much satisfactory!”

Pharmatech is now able to offer a high-quality solution for all customers looking for premium functional, nutraceutical or medicinal confectionery, produced in a pharmaceutical FDA-approved facility. The flexible nature of the production process allows to scale the batch size to the customer needs, starting from as little as 500 kg, meaning between 75,000 and 250,000 gummies.

For any enquiries about a collaboration with Rousselot, get in touch.